TherapeuticsMD, Inc. Share Price Today: Live Updates & Key Insights

TherapeuticsMD, Inc. share price today is $2.21, up 0.45%. The stock opened at $2.2374 against the previous close of $2.23, with an intraday high of $2.33 and low of $2.2374.

TherapeuticsMD, Inc. Share Price Chart

TherapeuticsMD, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

TherapeuticsMD, Inc. Share Price Performance

$2.21 0.0045(0.45%) TXMD at 23 Mar 2026 03:37 PM Drug Manufacturers - Specialty & Generic
Lowest Today 2.2374
Highest Today 2.33
Today’s Open 2.2374
Prev. Close 2.23
52 Week High 2.95
52 Week Low 0.83
Day’s Range: Low 2.2374 High 2.33
52-Week Range: Low 0.83 High 2.95
1 day return -
1 Week return -1.31
1 month return -3.0
3 month return +32.94
6 month return +123.76
1 year return +115.23
3 year return -35.88
5 year return -97.02
10 year return -

TherapeuticsMD, Inc. Institutional Holdings

Rubric Capital Management LP 10.30

Clearline Capital LP 5.49

Vanguard Group Inc 3.43

Tejara Capital Ltd 2.97

Vanguard Total Stock Mkt Idx Inv 2.11

ADAR1 Capital Management LLC 1.81

Morgan Stanley - Brokerage Accounts 1.13

BlackRock Inc 1.00

Geode Capital Management, LLC 0.92

Renaissance Technologies Corp 0.83

Vanguard Institutional Extnd Mkt Idx Tr 0.79

Fidelity Extended Market Index 0.58

Susquehanna International Group, LLP 0.30

State Street Corp 0.26

Citadel Advisors Llc 0.24

Blackrock Extended Mkt Fund CF 0.16

Bridgeway Capital Management, LLC 0.15

Bridgeway Ultra-Small Company Market 0.15

Northern Trust Corp 0.14

Extended Equity Market Fund K 0.14

Fidelity Series Total Market Index 0.13

Fidelity Total Market Index 0.13

Advisor Group Holdings, Inc. 0.08

NT Ext Equity Mkt Idx Fd - NL 0.08

Spartan Total Market Index Pool G 0.08

FMR Inc 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Fidelity OTC 0.06

Northern Trust Extended Eq Market Idx 0.06

NT Ext Equity Mkt Idx Fd - L 0.06

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

Vanguard U.S. Eq Idx £ Acc 0.04

Gabelli ABC I 0.03

State St US Extended Mkt Indx NL Cl C 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Tower Research Capital LLC 0.02

Extended Equity Market Fund M 0.02

Group One Trading, LP 0.01

NATIONAL BANK OF CANADA /FI/ 0.01

JPMorgan Chase & Co 0.01

TherapeuticsMD, Inc. Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

TherapeuticsMD, Inc. Fundamentals

Market Cap 25.93 M

PB Ratio 0.9489

PE Ratio 224.0

Enterprise Value 25.41 M

Total Assets 38.82 M

Volume 38397

TherapeuticsMD, Inc. Company Financials

Annual Revenue FY23:69366000 69.4M, FY22:69963000 70.0M, FY21:86951000 87.0M, FY20:64872280 64.9M, FY19:49646937 49.6M

Annual Profit FY23:69366000 69.4M, FY22:68566000 68.6M, FY21:68113000 68.1M, FY20:48897303 48.9M, FY19:43312352 43.3M

Annual Net worth FY23:68307000 68.3M, FY22:111997000 112.0M, FY21:-205604000 -205.6M, FY20:-212702827 -212.7M, FY19:-196027320 -196.0M

Quarterly Revenue Q3/2025:784000 0.8M, Q2/2025:952000 1.0M, Q1/2025:393000 0.4M, Q3/2024:547000 0.5M, Q2/2024:234000 0.2M

Quarterly Profit Q3/2025:784000 0.8M, Q2/2025:952000 1.0M, Q1/2025:393000 0.4M, Q3/2024:547000 0.5M, Q2/2024:234000 0.2M

Quarterly Net worth Q3/2025:152000 0.2M, Q2/2025:551000 0.6M, Q1/2025:-653000 -0.7M, Q3/2024:-609000 -0.6M, Q2/2024:-1090000 -1.1M

About TherapeuticsMD, Inc. & investment objective

Company Information TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Organisation Drug Manufacturers - Specialty & Generic

Employees 1

Industry Drug Manufacturers - Specialty & Generic

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

TherapeuticsMD, Inc. FAQs

What is the share price of TherapeuticsMD, Inc. today?

The current share price of TherapeuticsMD, Inc. is $2.21.

Can I buy TherapeuticsMD, Inc. shares in India?

Yes, Indian investors can buy TherapeuticsMD, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy TherapeuticsMD, Inc. shares in India?

You can easily invest in TherapeuticsMD, Inc. shares from India by:

Can I buy fractional shares of TherapeuticsMD, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of TherapeuticsMD, Inc.?

TherapeuticsMD, Inc. has a market cap of $25.93 M.

In which sector does TherapeuticsMD, Inc. belong?

TherapeuticsMD, Inc. operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in TherapeuticsMD, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of TherapeuticsMD, Inc.?

The PE ratio of TherapeuticsMD, Inc. is 224.00 and the PB ratio is 0.95.